- Home
- SGMO vs DLNG Comparison
SGMO vs DLNG Comparison
Compare SGMO & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- DLNG
- Stock Information
- Founded
- SGMO 1995
- DLNG 2013
- Country
- SGMO United States
- DLNG Greece
- Employees
- SGMO N/A
- DLNG N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- DLNG Marine Transportation
- Sector
- SGMO Health Care
- DLNG Consumer Discretionary
- Exchange
- SGMO Nasdaq
- DLNG Nasdaq
- Market Cap
- SGMO 122.8M
- DLNG 129.0M
- IPO Year
- SGMO 2000
- DLNG 2013
- Fundamental
- Price
- SGMO $0.54
- DLNG $3.49
- Analyst Decision
- SGMO Buy
- DLNG
- Analyst Count
- SGMO 6
- DLNG 0
- Target Price
- SGMO $4.50
- DLNG N/A
- AVG Volume (30 Days)
- SGMO 5.7M
- DLNG 34.0K
- Earning Date
- SGMO 08-12-2025
- DLNG 09-09-2025
- Dividend Yield
- SGMO N/A
- DLNG 5.54%
- EPS Growth
- SGMO N/A
- DLNG 53.29
- EPS
- SGMO N/A
- DLNG 1.10
- Revenue
- SGMO $63,756,000.00
- DLNG $157,455,000.00
- Revenue This Year
- SGMO $1.29
- DLNG N/A
- Revenue Next Year
- SGMO $1.60
- DLNG $0.37
- P/E Ratio
- SGMO N/A
- DLNG $3.22
- Revenue Growth
- SGMO 239.92
- DLNG N/A
- 52 Week Low
- SGMO $0.41
- DLNG $3.18
- 52 Week High
- SGMO $3.18
- DLNG $5.65
- Technical
- Relative Strength Index (RSI)
- SGMO 50.80
- DLNG 42.56
- Support Level
- SGMO $0.50
- DLNG $3.55
- Resistance Level
- SGMO $0.70
- DLNG $3.66
- Average True Range (ATR)
- SGMO 0.05
- DLNG 0.11
- MACD
- SGMO 0.01
- DLNG -0.01
- Stochastic Oscillator
- SGMO 29.17
- DLNG 16.00
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.